Revision of the International Pharmaceutical Federation's Basel Statements on the future of hospital pharmacy: From Basel to Bangkok.
نویسندگان
چکیده
PURPOSE The processes used to revise the 2008 Basel Statements on the future of hospital pharmacy are summarized, and the revised statements are presented. METHODS The process for revising the Basel Statements followed an approach similar to that used during their initial development. The Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP) revised the 2008 FIP Basel Statements in four phases, including a survey of hospital pharmacists worldwide, an internal review, online forums, and a face-to-face "World Café" workshop in Bangkok, Thailand. RESULTS The global survey on the initial Basel Statements included input from 334 respondents from 62 countries. The majority of respondents agreed that most of the initial Basel Statements were acceptable as written and did not require revision. In total, 11 statements were judged by more than 10% of respondents as needing revision or deletion. The FIP HPS executive committee used the survey results to develop 69 initial revised draft statements. After an online discussion with the international hospital pharmacy community, including individuals from 28 countries representing all six World Health Organization regions, a final set of draft statements was prepared for the live discussion involving participants from 20 countries. The final 65 revised Basel Statements were voted on and accepted. CONCLUSION Systematic revision of the FIP Basel Statements resulted in an updated reflection of aspirational goals for the future of hospital pharmacy practice. While this revision reflects the development of new goals for hospital pharmacy practice, the core principles of the Basel Statements remain an essential foundation for the discipline.
منابع مشابه
The Basel Statements on the future of hospital pharmacy.
The Global Conference on the Future of Hospital Pharmacy was hosted by the Hospital Pharmacy Section of the International Pharmaceutical Federation (FIP) as part of the 68th Annual Congress of FIP. Hospital pharmacists from around the globe met in Basel, Switzerland, on August 30 and 31, 2008, and successfully developed these consensus statements reflecting the profession’s preferred vision of ...
متن کاملMedicine procurement in hospital pharmacies of Nepal: A qualitative study based on the Basel Statements
BACKGROUND Accessibility and affordability of evidence-based medicines are issues of global concern. For low-income countries like Nepal, it is crucial to have easy and reliable access to affordable, good-quality, evidence-based medicines, especially in the aftermath of natural or manmade disasters. Availability of affordable and evidence-based high quality medicines depends on the medicine pro...
متن کاملThe Search for Underlying Principles of Health Impact Assessment: Progress and Prospects; Comment on “Investigating Underlying Principles to Guide Health Impact Assessment”
Health Impact Assessment (HIA) is a relatively young field of endeavour, and hence, future progress will depend on the planning, implementation and rigorous evaluation of additional HIAs of projects, programmes and policies the world over. In the June 2014 issue of the International Journal of Health Policy and Management, Fakhri and colleagues investigated underlying principles of HIA through ...
متن کاملUse of the 2008 basel consensus statements to assess, realign, and monitor pharmacy practice at a tertiary care hospital in northern Uganda: illustrative case study.
Pharmaciens sans frontières (also known as Pharmacists Without Borders—Canada or PSF-Canada) has an ongoing collaboration with St Mary’s Lacor Hospital (Lacor Hospital) in the Gulu district of northern Uganda. Founded by a group of Comboni missionaries in 1959 and developed by 2 physicians, Dr Lucille Teasdale and Dr Piero Corti, Lacor Hospital has grown from a small 30-bed institution to its c...
متن کاملPharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements
Background Pharmacovigilance (PV) data are crucial for ensuring safety and effectiveness of medicines after drugs have been granted marketing approval. This paper describes the PV systems of India, Uganda and South Africa based on literature and Key Informant (KI) interviews and compares them with the World Health Organization’s (WHO’s) minimum PV requirements for a Functional National PV Syste...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
دوره 73 14 شماره
صفحات -
تاریخ انتشار 2016